Cargando…

Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients

OBJECTIVES: Venovenous extracorporeal membrane oxygenation has been largely used in patients with refractory acute respiratory distress syndrome due to coronavirus disease 2019. Few data on long-term pulmonary function among venovenous extracorporeal membrane oxygenation survivors are available. DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Ego, Amédée, Taton, Olivier, Brasseur, Alexandre, Laurent, Yves, Taccone, Fabio Silvio, Courcelle, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288889/
https://www.ncbi.nlm.nih.gov/pubmed/34291224
http://dx.doi.org/10.1097/CCE.0000000000000494
_version_ 1783724180760428544
author Ego, Amédée
Taton, Olivier
Brasseur, Alexandre
Laurent, Yves
Taccone, Fabio Silvio
Courcelle, Romain
author_facet Ego, Amédée
Taton, Olivier
Brasseur, Alexandre
Laurent, Yves
Taccone, Fabio Silvio
Courcelle, Romain
author_sort Ego, Amédée
collection PubMed
description OBJECTIVES: Venovenous extracorporeal membrane oxygenation has been largely used in patients with refractory acute respiratory distress syndrome due to coronavirus disease 2019. Few data on long-term pulmonary function among venovenous extracorporeal membrane oxygenation survivors are available. DESIGN: Retrospective, observational cohort. SETTING: Two mixed medical-surgical tertiary (30 beds) and secondary (22 beds) ICUs. PATIENTS: All critically ill adult coronavirus disease 2019 survivors treated with venovenous extracorporeal membrane oxygenation between March 10, and April 30, 2020. MEASUREMENTS AND MAIN RESULTS: The last available lung function and 6-minute walking tests, performed after a median of 178 days (ranges, 72–232 d) from ICU admission, were analyzed. Among the 32 coronavirus disease 2019 patients treated by venovenous extracorporeal membrane oxygenation during the study period, 11 (34%; median age 56 yr; median duration of mechanical ventilation and extracorporeal membrane oxygenation therapy of 26 and 15 d, respectively) were successfully weaned and discharged home. Spirometry was performed in nine patients; the volumetric lung function was preserved, that is, median forced vital capacity was 83% of predicted value (51–99% of predicted value), and median forced expiratory volume in 1 second was 82% of predicted value (60–99% of predicted value). Also, the median residual volume and the lung capacity were 100% of predicted value (50–140% of predicted value) and 90% of predicted value (50–100% of predicted value); only the diffusion capacity of the lung for carbon monoxide and 6-minute walking test were decreased (58% of predicted value [37–95% of predicted value] and 468 meters (365–625 meters), corresponding to [63–90% of predicted value], respectively). CONCLUSIONS: Among survivors from severe coronavirus disease 2019 pneumonia treated with venovenous extracorporeal membrane oxygenation, preserved long-term volumetric lung function with decreased diffusion capacity of lung carbon monoxide was observed.
format Online
Article
Text
id pubmed-8288889
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82888892021-07-20 Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients Ego, Amédée Taton, Olivier Brasseur, Alexandre Laurent, Yves Taccone, Fabio Silvio Courcelle, Romain Crit Care Explor Brief Report OBJECTIVES: Venovenous extracorporeal membrane oxygenation has been largely used in patients with refractory acute respiratory distress syndrome due to coronavirus disease 2019. Few data on long-term pulmonary function among venovenous extracorporeal membrane oxygenation survivors are available. DESIGN: Retrospective, observational cohort. SETTING: Two mixed medical-surgical tertiary (30 beds) and secondary (22 beds) ICUs. PATIENTS: All critically ill adult coronavirus disease 2019 survivors treated with venovenous extracorporeal membrane oxygenation between March 10, and April 30, 2020. MEASUREMENTS AND MAIN RESULTS: The last available lung function and 6-minute walking tests, performed after a median of 178 days (ranges, 72–232 d) from ICU admission, were analyzed. Among the 32 coronavirus disease 2019 patients treated by venovenous extracorporeal membrane oxygenation during the study period, 11 (34%; median age 56 yr; median duration of mechanical ventilation and extracorporeal membrane oxygenation therapy of 26 and 15 d, respectively) were successfully weaned and discharged home. Spirometry was performed in nine patients; the volumetric lung function was preserved, that is, median forced vital capacity was 83% of predicted value (51–99% of predicted value), and median forced expiratory volume in 1 second was 82% of predicted value (60–99% of predicted value). Also, the median residual volume and the lung capacity were 100% of predicted value (50–140% of predicted value) and 90% of predicted value (50–100% of predicted value); only the diffusion capacity of the lung for carbon monoxide and 6-minute walking test were decreased (58% of predicted value [37–95% of predicted value] and 468 meters (365–625 meters), corresponding to [63–90% of predicted value], respectively). CONCLUSIONS: Among survivors from severe coronavirus disease 2019 pneumonia treated with venovenous extracorporeal membrane oxygenation, preserved long-term volumetric lung function with decreased diffusion capacity of lung carbon monoxide was observed. Lippincott Williams & Wilkins 2021-07-16 /pmc/articles/PMC8288889/ /pubmed/34291224 http://dx.doi.org/10.1097/CCE.0000000000000494 Text en Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Brief Report
Ego, Amédée
Taton, Olivier
Brasseur, Alexandre
Laurent, Yves
Taccone, Fabio Silvio
Courcelle, Romain
Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
title Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
title_full Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
title_fullStr Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
title_full_unstemmed Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
title_short Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
title_sort six-month pulmonary function after venovenous extracorporeal membrane oxygenation for coronavirus disease 2019 patients
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288889/
https://www.ncbi.nlm.nih.gov/pubmed/34291224
http://dx.doi.org/10.1097/CCE.0000000000000494
work_keys_str_mv AT egoamedee sixmonthpulmonaryfunctionaftervenovenousextracorporealmembraneoxygenationforcoronavirusdisease2019patients
AT tatonolivier sixmonthpulmonaryfunctionaftervenovenousextracorporealmembraneoxygenationforcoronavirusdisease2019patients
AT brasseuralexandre sixmonthpulmonaryfunctionaftervenovenousextracorporealmembraneoxygenationforcoronavirusdisease2019patients
AT laurentyves sixmonthpulmonaryfunctionaftervenovenousextracorporealmembraneoxygenationforcoronavirusdisease2019patients
AT tacconefabiosilvio sixmonthpulmonaryfunctionaftervenovenousextracorporealmembraneoxygenationforcoronavirusdisease2019patients
AT courcelleromain sixmonthpulmonaryfunctionaftervenovenousextracorporealmembraneoxygenationforcoronavirusdisease2019patients